Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05302908 · ClinicalTrials.gov registry record · NA

COVID-19 Testing and Vaccination Among Spanish Speakers

A NA study of COVID-19 and Vaccinations, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
274
Enrollment target
1
Study location

NCT05302908 is a NA study of COVID-19 and Vaccinations that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 274 participants, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05302908, a NA study of COVID-19 and Vaccinations, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
274 participants
Enrollment target
1
Study location

Study Summary

Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major barriers to COVID-19 testing and vaccination exist, and a profound need remains to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing and vaccination within Latinx communities. Our community-academic partnership proposes a rigorous mixed-methods, community-based participatory research study to better understand the SEBI of COVID-19 testing and vaccination and to refine and test a novel and culturally congruent intervention that integrates two evidenced-based strategies - peer navigation and mHealth - to increase COVID-19 testing and vaccination within Spanish-speaking Latinx communities.

Conditions Studied

Interventions

  • BEHAVIORAL NuestraSaludSegura

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 274 participants
Start Date 2023-02-09
Est. Completion 2024-11-30
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05302908

The ClinicalTrials.gov registry entry for NCT05302908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which NuestraSaludSegura is the first listed.

NCT05302908 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05302908 about?

NCT05302908 is a clinical study titled "COVID-19 Testing and Vaccination Among Spanish Speakers". Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major barriers to COVID-19 testing and vaccination exist, and a profound need remains to understand and ad...

What is the current status of trial NCT05302908?

This trial is currently completed. It is a NA study. The enrollment target is 274 participants. The study started on 2023-02-09. Estimated completion is 2024-11-30.

What conditions does trial NCT05302908 study?

This clinical trial studies the following conditions: COVID-19, Vaccinations.

What interventions are being tested in trial NCT05302908?

The interventions under investigation include: NuestraSaludSegura (BEHAVIORAL).

Who is sponsoring clinical trial NCT05302908?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05302908 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.